Infectious Disease

The use of probiotics, fecal microbiota transplants, and live biotherapeutics have been effective in phase 3 studies that focus on Clostridioides difficile infection (CDI).

The US government has set a goal of achieving viral clearance in 80% of patients by 2030.

Modeling done based on data from a single hospital suggests a transmission-prevention regime meaningfully reduced hospital-onset Clostridioides difficile infection (CDI).

Investigators say their data show the importance of vaccination and antibiotic stewardship programs.

Shifts in clinical treatment patterns could prompt investigators to revisit the cost-effectiveness question.

The risk of CDI increased at a tertiary hospital, but not at the 2 community hospitals included in the study.

Randomized controlled trials had lower rates of success, but microbiota restoration still out-performed antibiotics.

Moving to co-administration could also help more adults catch up with vaccination recommendations, the authors said.

Hospitals with the highest work-environment scores were less likely to have above-average Clostridioides difficile infection (CDI) rates.

The plan aims to reverse a significant surge in sexually transmitted infections, including gonorrhea, syphilis, and chlamydia.

However, Clostridioides difficile (CDI) infection did not appear to affect outcomes, according to the study.

New studies seem to show 2 doses of mpox vaccine more effective than 1; US drug overdoses peaked in 2022; fertility app Premom will pay $200,000 after sharing sensitive user data.

Using a diverse human gut community, researchers investigated how gut microbiota interspecies interactions affected the response of Clostridioides difficile to vancomycin and metronidazole.

The Clostridioides difficile study was presented at Digestive Disease Week in Chicago.

Mailing at-home human papillomavirus (HPV) self-collection tests and providing booking assistance for in-clinic screening visits nearly doubled the rate of cervical cancer screenings among underscreened women from low-income backgrounds vs offering scheduling assistance alone.

The prevalence of Clostridioides difficile has risen in recent years, and although its carriage is recognized in infancy, limited data exist on its longitudinal trends.

Fecal microbiota transplantation (FMT) has emerged as a highly successful therapeutic strategy for recurrent Clostridioides difficile infection (CDI) in recent years.

CDC Director Rochelle Walensky, MD, said she will leave the agency at the end of June, a few hours after the World Health Organization (WHO) ended the global emergency status for COVID-19 on Friday.

The authors of the study noted the importance of balancing resources available with efficient use of them and to use tailored tools so improve efficiency.

Survey findings indicate the program was an essential service during the pandemic.

Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, reviews emerging therapeutics being investigated for the prevention and treatment of Clostridioides difficile infection (CDI).

Attendees at the Society for Healthcare Epidemiology of America (SHEA) 2023 Spring Conference heard presentations about using electronic health records to identify cases of Clostridioides difficile earlier, as well as an update about infection control strategies.

Although new guidelines from the CDC say that masks need not be worn in counties where transmission level for COVID-19 isn’t high, many health systems still plan to mask.

The cost savings for health plans would increase if the therapy were used after the first recurrence of Clostridioides difficile infection (CDI).

CMS finalizes plans to decrease overpayments to Medicare Advantage insurers; an experimental respiratory syncytial virus (RSV) vaccine is highly effective in infants when given to pregnant women; obesity may be influenced by different brain factors between men and women.